Continuous monitoring of glucose levels with a micro-organ based microfluidic biosensor

Emilie Puginier,Antoine Pirog,Florence Poulletier de Gannes,Julien Gaitan,Annabelle Hurtier,Marie Monchablon,Matthieu Raoux,Sylvie Renaud,Jochen Lang
DOI: https://doi.org/10.1101/2024.04.03.587710
2024-04-04
Abstract:Continuous monitoring of glucose levels has improved diabetes therapy. Current approaches rely on enzyme-linked electrochemical probes but do not allow a fully autonomous artificial pancreas. In contrast, monitoring the activity of a few electrogenic pancreatic islets in a biosensor may harness the computational power of the different endocrine cell types in the micro-organ, shaped for nutrient detection during evolution, and provide a more appropriate read-out. Extracellular electrophysiology captures slow potentials (SPs), which reflect coupled islet β-cell activity and is thus a method of choice for long-term monitoring of native islet activity . We have now developed a microfluidic microelectrode chip containing a few islets and linked to interstitial fluids in live rats by subcutaneous microdialysis. The electrical activity in terms of slow potentials monitored by this biosensor reacts proportionally to glucose levels off-line in serum or dialysed interstitial fluid. On-line monitoring reveals an excellent correlation between islet slow potential frequency, and to a lesser degree to slow potential amplitudes, to glucose concentrations with little variation between animals. The microorgan-based biosensor harness multiple parameters and provides a read-out closer to physiology. This demonstrates the usefulness of such biosensors for sensor-based therapy of diabetes.
Physiology
What problem does this paper attempt to address?
The paper attempts to address the development of a microfluidic biosensor based on micro-organs for continuous in vivo monitoring of glucose levels. Current blood glucose monitoring methods primarily rely on enzyme-linked electrochemical probes, but these methods cannot achieve a fully autonomous artificial pancreas. In contrast, by monitoring the activity of a few electroactive islets in the biosensor, the computational capabilities of different endocrine cell types within these micro-organs, which have evolved to detect nutrients, can be utilized to provide more appropriate readings. Specifically, the study aims to: 1. **Develop a novel biosensor**: This biosensor can monitor glucose levels through several islets in a microfluidic chip and connect with the interstitial fluid of live rats via subcutaneous microdialysis. 2. **Validate the performance of the biosensor**: Through in vitro and in vivo experiments, validate the biosensor's response to different glucose concentrations and assess its effectiveness and accuracy in continuous blood glucose monitoring. 3. **Explore the potential application of the biosensor in diabetes treatment**: Investigate whether this micro-organ-based biosensor can serve as a more physiological and safer sensor for sensor-based diabetes treatment, particularly in artificial pancreas systems. In summary, the goal of this study is to develop a new islet-based biosensor to achieve more accurate and physiological continuous blood glucose monitoring, thereby improving the effectiveness and safety of diabetes treatment.